全文获取类型
收费全文 | 2713篇 |
免费 | 203篇 |
国内免费 | 50篇 |
专业分类
耳鼻咽喉 | 8篇 |
儿科学 | 23篇 |
妇产科学 | 13篇 |
基础医学 | 326篇 |
口腔科学 | 35篇 |
临床医学 | 372篇 |
内科学 | 245篇 |
皮肤病学 | 51篇 |
神经病学 | 178篇 |
特种医学 | 192篇 |
外科学 | 190篇 |
综合类 | 559篇 |
一般理论 | 1篇 |
预防医学 | 402篇 |
眼科学 | 16篇 |
药学 | 241篇 |
中国医学 | 27篇 |
肿瘤学 | 87篇 |
出版年
2024年 | 3篇 |
2023年 | 65篇 |
2022年 | 93篇 |
2021年 | 140篇 |
2020年 | 110篇 |
2019年 | 145篇 |
2018年 | 150篇 |
2017年 | 105篇 |
2016年 | 93篇 |
2015年 | 102篇 |
2014年 | 244篇 |
2013年 | 216篇 |
2012年 | 216篇 |
2011年 | 247篇 |
2010年 | 219篇 |
2009年 | 146篇 |
2008年 | 168篇 |
2007年 | 134篇 |
2006年 | 84篇 |
2005年 | 53篇 |
2004年 | 49篇 |
2003年 | 33篇 |
2002年 | 19篇 |
2001年 | 16篇 |
2000年 | 22篇 |
1999年 | 16篇 |
1998年 | 4篇 |
1997年 | 11篇 |
1996年 | 5篇 |
1995年 | 16篇 |
1994年 | 17篇 |
1993年 | 2篇 |
1991年 | 1篇 |
1990年 | 1篇 |
1988年 | 3篇 |
1986年 | 3篇 |
1985年 | 5篇 |
1984年 | 2篇 |
1983年 | 3篇 |
1982年 | 2篇 |
1977年 | 1篇 |
1974年 | 1篇 |
1973年 | 1篇 |
排序方式: 共有2966条查询结果,搜索用时 15 毫秒
1.
2.
《药学学报(英文版)》2020,10(5):799-811
Overexpression of adenosine triphosphate (ATP)-binding cassette subfamily G member 2 (ABCG2) in cancer cells is known to cause multidrug resistance (MDR), which severely limits the clinical efficacy of chemotherapy. Currently, there is no FDA-approved MDR modulator for clinical use. In this study, rociletinib (CO-1686), a mutant-selective epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI), was found to significantly improve the efficacy of ABCG2 substrate chemotherapeutic agents in the transporter-overexpressing cancer cells in vitro and in MDR tumor xenografts in nude mice, without incurring additional toxicity. Mechanistic studies revealed that in ABCG2-overexpressing cancer cells, rociletinib inhibited ABCG2-mediated drug efflux and increased intracellular accumulation of ABCG2 probe substrates. Moreover, rociletinib, inhibited the ATPase activity, and competed with [125I] iodoarylazidoprazosin (IAAP) photolabeling of ABCG2. However, ABCG2 expression at mRNA and protein levels was not altered in the ABCG2-overexpressing cells after treatment with rociletinib. In addition, rociletinib did not inhibit EGFR downstream signaling and phosphorylation of protein kinase B (AKT) and extracellular signal-regulated kinase (ERK). Our results collectively showed that rociletinib reversed ABCG2-mediated MDR by inhibiting ABCG2 efflux function, thus increasing the cellular accumulation of the transporter substrate anticancer drugs. The findings advocated the combination use of rociletinib and other chemotherapeutic drugs in cancer patients with ABCG2-overexpressing MDR tumors. 相似文献
3.
目的:探讨Acsl4在浸润性乳腺癌组织中的表达及其临床意义。方法:采用免疫组织化学法检测108例浸润性乳腺癌组织中Acsl4的表达。结果:108例浸润性乳腺癌组织中,33例(30.6%)阳性表达,75例(69.4%)阴性表达。组织学G3级的乳腺癌组织中Acsl4阳性率为42.3%(22/52),高于G1+G2级的阳性率(19.6%,11/56),差异具有统计学意义(P<0.05)。ER阳性组织的Acsl4的阳性率15.8%(6/38),低于ER阴性的病例(38.6%,27/70),差异具有统计学意义(P<0.05)。Acsl4的表达与患者年龄、肿瘤大小、淋巴结是否转移、HER2、PR、p53、Ki67的表达情况无统计学意义的相关性(P均>0.05)。结论:Acsl4在浸润性乳腺癌组织中存在异常表达,其阳性表达与乳腺癌患者组织学分级较高及ER阴性表达密切相关。 相似文献
4.
5.
6.
《Clinical neurophysiology》2021,132(12):3104-3115
ObjectiveWe aimed to establish an objective neurophysiological test protocol that can be used to assess the somatosensory nervous system.MethodsIn order to assess most fiber subtypes of the somatosensory nervous system, repetitive stimuli of seven different modalities (touch, vibration, pinprick, cold, contact heat, laser, and warmth) were synchronized with the electroencephalogram (EEG) and applied on the cheek and dorsum of the hand and dorsum of the foot in 21 healthy subjects and three polyneuropathy (PNP) patients. Latencies and amplitudes of the modalities were assessed and compared. Patients received quantitative sensory testing (QST) as reference.ResultsWe found reproducible evoked potentials recordings for touch, vibration, pinprick, contact-heat, and laser stimuli. The recording of warm-evoked potentials was challenging in young healthy subjects and not applicable in patients. Latencies were shortest within Aβ-fiber-mediated signals and longest within C-fibers. The test protocol detected function loss within the Aβ-fiber and Aδ-fiber-range in PNP patients. This function loss corresponded with QST findings.ConclusionIn this pilot study, we developed a neurophysiological test protocol that can specifically assess most of the somatosensory modalities. Despite technical challenges, initial patient data appear promising regarding a possible future clinical application.SignificanceEstablished and custom-made stimulators were combined to assess different fiber subtypes of the somatosensory nervous system using modality-specific evoked potentials. 相似文献
7.
8.
9.
10.
Joseph M. Currier Steven L. Isaak Ryon C. McDermott 《Clinical psychology & psychotherapy》2020,27(1):61-68
Military personnel may encounter morally injurious events that lead to emotional, social, and spiritual suffering that transcend and/or overlap with mental health diagnoses (e.g., post‐traumatic stress disorder [PTSD]). Advancement of scientific research and potential clinical innovation for moral injury (MI) requires a diversity of measurement approaches. Drawing on results from the bifactor model in Currier et al.'s (2017) psychometric evaluation of the Expressions of Moral Injury Scale‐Military version (EMIS‐M), this study validated a four‐item short form of the instrument with two samples of veterans with a history of war‐zone service. Namely, despite the reduced number of items, the EMIS‐M‐Short Form (SF) yielded favourable internal consistency and comparable levels of convergent validity with theoretically related constructs (e.g., PTSD and struggles with morality and ultimate meaning) as the full‐length version. Notwithstanding the possible utility of distinguishing between self‐ and other‐directed forms of MI, factor analytic results further revealed that the EMIS‐M‐SF was best conceptualized with a unidimensional factorial model that might allow for a general assessment of MI‐related outcomes. Overall, these initial results suggest that the EMIS‐M‐SF may hold promise as a short, reliable, and valid assessment of overall outcomes related to a possible MI. 相似文献